The Role of Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate in Novel Drug Development
The relentless pursuit of novel therapeutics in the pharmaceutical industry relies heavily on the availability of advanced chemical intermediates. Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate, with CAS number 756525-95-8, is one such pivotal compound, playing a significant role in the synthesis of next-generation drugs. Its unique chemical structure, characterized by the formula C11H23NO4 and a molecular weight of 233.30500, offers valuable functionalities for constructing complex drug molecules. With a purity of 97%+, it meets the exacting standards required for pharmaceutical applications.
The diethylene glycol ether backbone of Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate can enhance the solubility and bioavailability of drug candidates. This makes it an attractive intermediate for developing drugs targeting various therapeutic areas. The presence of both an amino group and a protected carboxylic acid (tert-butyl ester) allows for sequential chemical modifications, enabling the creation of diverse molecular architectures. This versatility is crucial for medicinal chemists designing libraries of compounds for screening and optimization, thereby accelerating the drug discovery process. Partnering with a reliable chemical intermediates supplier in China ensures consistent access to this vital material.
As a key pharmaceutical intermediate, Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate is often integrated into linker strategies for antibody-drug conjugates (ADCs) or used in the synthesis of PROTAC molecules, both cutting-edge modalities in targeted cancer therapy. The ability to buy this compound from a trusted source like a leading Chinese manufacturer means researchers and developers can confidently integrate it into their innovative drug development pipelines. Proper storage, maintaining its integrity under specific conditions (dark, inert atmosphere, 2-8°C), is a testament to the quality assurance provided by dedicated suppliers, ensuring its effectiveness in driving forward the future of medicine.
The diethylene glycol ether backbone of Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate can enhance the solubility and bioavailability of drug candidates. This makes it an attractive intermediate for developing drugs targeting various therapeutic areas. The presence of both an amino group and a protected carboxylic acid (tert-butyl ester) allows for sequential chemical modifications, enabling the creation of diverse molecular architectures. This versatility is crucial for medicinal chemists designing libraries of compounds for screening and optimization, thereby accelerating the drug discovery process. Partnering with a reliable chemical intermediates supplier in China ensures consistent access to this vital material.
As a key pharmaceutical intermediate, Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate is often integrated into linker strategies for antibody-drug conjugates (ADCs) or used in the synthesis of PROTAC molecules, both cutting-edge modalities in targeted cancer therapy. The ability to buy this compound from a trusted source like a leading Chinese manufacturer means researchers and developers can confidently integrate it into their innovative drug development pipelines. Proper storage, maintaining its integrity under specific conditions (dark, inert atmosphere, 2-8°C), is a testament to the quality assurance provided by dedicated suppliers, ensuring its effectiveness in driving forward the future of medicine.
Perspectives & Insights
Alpha Spark Labs
“Partnering with a reliable chemical intermediates supplier in China ensures consistent access to this vital material.”
Future Pioneer 88
“As a key pharmaceutical intermediate, Tert-butyl 3-(2-(2-aminoethoxy)ethoxy)propanoate is often integrated into linker strategies for antibody-drug conjugates (ADCs) or used in the synthesis of PROTAC molecules, both cutting-edge modalities in targeted cancer therapy.”
Core Explorer Pro
“The ability to buy this compound from a trusted source like a leading Chinese manufacturer means researchers and developers can confidently integrate it into their innovative drug development pipelines.”